BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37440955)

  • 1. Characterization of Circulating Tumor Cells Using Imaging Flow Cytometry in Liver Disease Patients.
    Debnath P; Dalal K; Dalal B; Athalye S; Chandnani S; Jain S; Shukla A; Rathi P; Shankarkumar A
    J Clin Exp Hepatol; 2023; 13(4):608-617. PubMed ID: 37440955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma.
    Takahashi K; Ofuji K; Hiramatsu K; Nosaka T; Naito T; Matsuda H; Endo K; Higuchi M; Ohtani M; Nemoto T; Nakamoto Y
    Cancer Med; 2021 Apr; 10(7):2300-2309. PubMed ID: 33675149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
    Nam SJ; Yeo HY; Chang HJ; Kim BH; Hong EK; Park JW
    Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
    Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma.
    Prasoppokakorn T; Buntho A; Ingrungruanglert P; Tiyarattanachai T; Jaihan T; Kulkraisri K; Ariyaskul D; Phathong C; Israsena N; Rerknimitr R; Treeprasertsuk S; Chaiteerakij R
    Sci Rep; 2022 Nov; 12(1):18686. PubMed ID: 36333384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular Carcinoma-Circulating Tumor Cells Expressing PD-L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors.
    Winograd P; Hou S; Court CM; Lee YT; Chen PJ; Zhu Y; Sadeghi S; Finn RS; Teng PC; Wang JJ; Zhang Z; Liu H; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Hepatol Commun; 2020 Oct; 4(10):1527-1540. PubMed ID: 33024921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
    Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
    Zhao L; Zheng Z; Liu Y; Liu F; Li X; Wu Z
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6035-6048. PubMed ID: 36633681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
    Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
    BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
    Ogle LF; Orr JG; Willoughby CE; Hutton C; McPherson S; Plummer R; Boddy AV; Curtin NJ; Jamieson D; Reeves HL
    J Hepatol; 2016 Aug; 65(2):305-13. PubMed ID: 27132171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma.
    Hu CL; Zhang YJ; Zhang XF; Fei X; Zhang H; Li CG; Sun B
    Onco Targets Ther; 2021; 14():2673-2688. PubMed ID: 33888992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma.
    Varillas JI; Zhang J; Chen K; Barnes II; Liu C; George TJ; Fan ZH
    Theranostics; 2019; 9(5):1417-1425. PubMed ID: 30867841
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma.
    Lei Y; Wang X; Sun H; Fu Y; Tian Y; Yang L; Wang J; Xia F
    Front Oncol; 2021; 11():601668. PubMed ID: 34123777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
    Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
    Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation.
    Chen Z; Lin X; Chen C; Chen Y; Zhao Q; Wu L; Wang D; Ma Y; Ju W; Chen M; He X
    Ann Transl Med; 2020 Sep; 8(17):1067. PubMed ID: 33145286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation.
    Hwang HS; Yoo JE; Han DH; Choi JS; Lee JG; Joo DJ; Kim MS; Kim SI; Choi GH; Park YN
    Gut Liver; 2022 May; 16(3):443-455. PubMed ID: 34737243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
    BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.